- $157.67m
- $76.67m
- $79.87m
Annual balance sheet for Sight Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 61.5 | 261 | 185 | 138 | 120 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5.36 | 8.71 | 15.1 | 14.3 | 10.8 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 70.6 | 277 | 210 | 163 | 140 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.79 | 2.95 | 3.19 | 3.1 | 2.52 |
| Other Long Term Assets | |||||
| Total Assets | 72.8 | 280 | 213 | 167 | 143 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 9.31 | 13.5 | 17.8 | 12.3 | 15.5 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 44.3 | 48.1 | 53 | 46.4 | 55.3 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 28.5 | 232 | 160 | 120 | 87.5 |
| Total Liabilities & Shareholders' Equity | 72.8 | 280 | 213 | 167 | 143 |
| Total Common Shares Outstanding |